195 related articles for article (PubMed ID: 10482689)
1. Fas expression prevents cholangiocarcinoma tumor growth.
Pickens A; Pan G; McDonald JM; Vickers SM
J Gastrointest Surg; 1999; 3(4):374-81; discussion 382. PubMed ID: 10482689
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin.
Pan G; Vickers SM; Pickens A; Phillips JO; Ying W; Thompson JA; Siegal GP; McDonald JM
Am J Pathol; 1999 Jul; 155(1):193-203. PubMed ID: 10393851
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma).
Vickers SM; Jhala NC; Ahn EY; McDonald JM; Pan G; Bland KI
Ann Surg; 2002 Jun; 235(6):872-8. PubMed ID: 12035045
[TBL] [Abstract][Full Text] [Related]
4. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T
Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the expression of Fas antigen and Fas ligand in a human submandibular gland ductal cell line by okadaic acid.
Morimoto Y; Morimoto H; Okamura H; Nomiyama K; Nakamuta N; Kobayashi S; Kito S; Ohba T; Haneji T
Arch Oral Biol; 2000 Aug; 45(8):657-66. PubMed ID: 10869477
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells.
Wang Y; Matsuo H; Kurachi O; Maruo T
Eur J Endocrinol; 2002 Mar; 146(3):447-56. PubMed ID: 11888853
[TBL] [Abstract][Full Text] [Related]
7. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
[TBL] [Abstract][Full Text] [Related]
8. Expression of Fas-Fas ligand in murine testis.
Xu JP; Li X; Mori E; Guo MW; Matsuda I; Takaichi H; Amano T; Mori T
Am J Reprod Immunol; 1999 Dec; 42(6):381-8. PubMed ID: 10622469
[TBL] [Abstract][Full Text] [Related]
9. Expression of Fas and Fas ligand in human gastric adenomas and intestinal-type carcinomas: correlation with proliferation and apoptosis.
Osaki M; Kase S; Kodani I; Watanabe M; Adachi H; Ito H
Gastric Cancer; 2001; 4(4):198-205. PubMed ID: 11846063
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cell death in NR-S1 tumor by photodynamic therapy: possible involvement of Fas and Fas ligand system.
Yokota T; Ikeda H; Inokuchi T; Sano K; Koji T
Lasers Surg Med; 2000; 26(5):449-60. PubMed ID: 10861700
[TBL] [Abstract][Full Text] [Related]
11. Alteration of Fas/FasL expression of oral squamous cell carcinoma cell line Tca83 induced by retinoic acid.
Guan WQ; Yu SF; Gao Y
Chin J Dent Res; 2000 Dec; 3(4):35-9. PubMed ID: 11314085
[TBL] [Abstract][Full Text] [Related]
12. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
Yao H; Song E; Chen J; Hamar P
Br J Cancer; 2004 Nov; 91(9):1718-25. PubMed ID: 15494722
[TBL] [Abstract][Full Text] [Related]
13. Partial tolerance of subcutaneously transplanted xenogeneic tumour cell graft by Fas-mediated immunosuppression.
Sawada T; Koji T; Hishikawa Y; Kishimoto K; Nagayasu T; Takahashi T; Oka T; Ayabe H
Immunology; 2001 May; 103(1):81-9. PubMed ID: 11380695
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in placentas of pregnant mice exposed to lipopolysaccharides: possible involvement of Fas/Fas ligand system.
Ejima K; Koji T; Tsuruta D; Nanri H; Kashimura M; Ikeda M
Biol Reprod; 2000 Jan; 62(1):178-85. PubMed ID: 10611083
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.
Micheau O; Solary E; Hammann A; Martin F; Dimanche-Boitrel MT
J Natl Cancer Inst; 1997 Jun; 89(11):783-9. PubMed ID: 9182976
[TBL] [Abstract][Full Text] [Related]
17. Role of fas ligand in uveal melanoma-induced liver damage.
Repp AC; Mayhew ES; Howard K; Alizadeh H; Niederkorn JY
Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):752-8. PubMed ID: 11760036
[TBL] [Abstract][Full Text] [Related]
18. Ageing of human epidermis: the role of apoptosis, Fas and telomerase.
Gilhar A; Ullmann Y; Karry R; Shalaginov R; Assy B; Serafimovich S; Kalish RS
Br J Dermatol; 2004 Jan; 150(1):56-63. PubMed ID: 14746617
[TBL] [Abstract][Full Text] [Related]
19. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells.
Jo SK; Cha DR; Cho WY; Kim HK; Chang KH; Yun SY; Won NH
Nephron; 2002 Jul; 91(3):406-15. PubMed ID: 12119470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
